Cancer Terms

Zirconium-Zr 89 Cetuximab

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Radiopharmaceutical Compound -> Radioconjugate -> Zirconium-Zr 89 Cetuximab

Zirconium-Zr 89 Cetuximab Definition

A radioimmunoconjugate comprised of the recombinant chimeric monoclonal antibody cetuximab labeled with the radioisotope zirconium Zr 89 (Zr 89) with radioisotopic activity and potential imaging use. The antibody moiety of zirconium Zr 89 cetuximab binds to the extracellular domain of the epidermal growth factor receptor (EGFR). Upon binding, the radioisotope moiety may be detected using positron emission tomography (PET), allowing the imaging and quantification of EGFR-expressing tumor cells. EGFR is a tyrosine kinase that may be overexpressed on the cell surfaces of various tumor cell types.

Zirconium-Zr 89 Cetuximab Synonyms

Zirconium Zr 89 Cetuximab, Cetuximab-Zirconium-89, Cetuximab-Zr-89, Zirconium-89-Labeled Cetuximab

Terms in Zirconium-Zr 89 Cetuximab category



Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods

No reproduction or republication permitted.